MedPath

Efficacy of Aloe Vera gel in systolic heart failure

Phase 3
Conditions
Systolic heart failure.
Chronic systolic (congestive) heart failure
I50.22
Registration Number
IRCT20190803044426N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
26
Inclusion Criteria

Written informed consent
Age: 18 years or above
Systolic heart failure disease with reduced left ventricular ejection fraction =40% or Symptomatic chronic heart failure NYHA class II-III.
Patients willing to continue their standard continuing heart medications which prescribed by cardiologist
Ambulatory systolic heart failure patients in stable condition (no hospitalization during the trial and no planned surgery)

Exclusion Criteria

Pregnancy
Breast feeding
Hypersensitivity to Aloe Vera
Chronic Inflammatory disease
Collagen vascular disease
History of peptic ulcer
Acute infectious disease
Decompensated heart failure
Chronic liver disease
Chronic renal failure
Hemorrhoids
Malignancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of Life Score in the Minnesota Questionnaire. Timepoint: Measure the quality of life score at the beginning of study(before intervention)and one week after taking Aloe Vera gel. Method of measurement: Minnesota Living With Heart Failure Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath